{"id":66611,"date":"2026-05-28T21:54:38","date_gmt":"2026-05-28T13:54:38","guid":{"rendered":"https:\/\/flcube.com\/?p=66611"},"modified":"2026-05-28T21:54:40","modified_gmt":"2026-05-28T13:54:40","slug":"vectorbuilder-commits-50-million-to-chicago-biomanufacturing-hub-integrated-rd-and-gmp-facility-to-streamline-gene-delivery-product-development","status":"publish","type":"post","link":"https:\/\/flcube.com\/?p=66611","title":{"rendered":"VectorBuilder Commits $50 Million to Chicago Biomanufacturing Hub \u2013 Integrated R&amp;D and GMP Facility to Streamline Gene Delivery Product Development"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\"><strong>VectorBuilder<\/strong>, a China-based gene delivery technology developer, announced plans to invest <strong>USD 50 million<\/strong> to establish an advanced biomanufacturing and research &amp; development center in <strong>Chicago, USA<\/strong>. The integrated facility will unify the company&#8217;s complete gene delivery product portfolio under a single operational framework, addressing critical industry challenges in translational efficiency and manufacturing continuity.<\/p>\n\n\n\n<h2 id=\"h-investment-overview\" class=\"wp-block-heading\">Investment Overview<\/h2>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><thead><tr><th>Component<\/th><th>Detail<\/th><\/tr><\/thead><tbody><tr><td><strong>Company<\/strong><\/td><td>VectorBuilder (China-based gene delivery technology developer)<\/td><\/tr><tr><td><strong>Investment Amount<\/strong><\/td><td>USD 50 million<\/td><\/tr><tr><td><strong>Location<\/strong><\/td><td>Chicago, Illinois, USA<\/td><\/tr><tr><td><strong>Facility Type<\/strong><\/td><td>Integrated R&amp;D and GMP biomanufacturing center<\/td><\/tr><tr><td><strong>Timeline<\/strong><\/td><td>Initial operations expected in 2027, with phased capacity expansion<\/td><\/tr><tr><td><strong>Strategic Rationale<\/strong><\/td><td>Address fragmented development models and high transition costs in gene therapy manufacturing<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<h2 id=\"h-product-portfolio-integration\" class=\"wp-block-heading\">Product Portfolio Integration<\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Comprehensive Coverage:<\/strong> Full spectrum of gene delivery technologies including:<\/li>\n\n\n\n<li><strong>Plasmids<\/strong> \u2013 foundational DNA constructs for gene expression<\/li>\n\n\n\n<li><strong>Recombinant viral vectors<\/strong> \u2013 engineered viral delivery systems for gene therapy<\/li>\n\n\n\n<li><strong>IVT RNA<\/strong> \u2013 in vitro transcribed RNA for transient gene expression applications<\/li>\n\n\n\n<li><strong>Genetically engineered cells<\/strong> \u2013 modified cellular products for therapeutic and research use<\/li>\n\n\n\n<li><strong>Unified Platform:<\/strong> Single facility integrates research, process development, and GMP manufacturing<\/li>\n\n\n\n<li><strong>Technology Harmonization:<\/strong> Standardized processes across all product modalities<\/li>\n\n\n\n<li><strong>Quality Systems:<\/strong> Integrated quality management from research through commercial production<\/li>\n<\/ul>\n\n\n\n<h2 id=\"h-industry-challenge-addressed\" class=\"wp-block-heading\">Industry Challenge Addressed<\/h2>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><thead><tr><th>Traditional Model Limitation<\/th><th>VectorBuilder Solution<\/th><\/tr><\/thead><tbody><tr><td><strong>Fragmented Development Stages<\/strong><\/td><td>End-to-end integration from research to GMP manufacturing<\/td><\/tr><tr><td><strong>High Transition Costs<\/strong><\/td><td>Eliminated handoffs between separate R&amp;D and manufacturing entities<\/td><\/tr><tr><td><strong>Process Inconsistency<\/strong><\/td><td>Unified technology and production processes across product types<\/td><\/tr><tr><td><strong>Timeline Delays<\/strong><\/td><td>Streamlined development pathway accelerates project translation<\/td><\/tr><tr><td><strong>Quality Variability<\/strong><\/td><td>Consistent quality standards maintained throughout development continuum<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<p class=\"wp-block-paragraph\">The integrated approach represents a paradigm shift from the traditional contract development and manufacturing organization (CDMO) model, where multiple vendors handle different stages of development.<\/p>\n\n\n\n<h2 id=\"h-strategic-market-positioning\" class=\"wp-block-heading\">Strategic Market Positioning<\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>U.S. Market Access:<\/strong> Chicago location provides proximity to major academic medical centers and biotechnology hubs<\/li>\n\n\n\n<li><strong>Global Capability:<\/strong> Complements existing China operations with Western hemisphere manufacturing capacity<\/li>\n\n\n\n<li><strong>Regulatory Strategy:<\/strong> U.S.-based GMP facility facilitates FDA compliance for North American clients<\/li>\n\n\n\n<li><strong>Customer Base:<\/strong> Serves both academic researchers and commercial biopharmaceutical companies<\/li>\n\n\n\n<li><strong>Competitive Differentiation:<\/strong> Integrated model offers cost and timeline advantages over fragmented alternatives<\/li>\n<\/ul>\n\n\n\n<h2 id=\"h-implementation-timeline-amp-capacity-planning\" class=\"wp-block-heading\">Implementation Timeline &amp; Capacity Planning<\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Phase 1 (2027):<\/strong> Initial operations commence with core capabilities across all product modalities<\/li>\n\n\n\n<li><strong>Phase 2 (2028-2029):<\/strong> Gradual capacity expansion based on customer demand patterns<\/li>\n\n\n\n<li><strong>Phase 3 (2030+):<\/strong> Full-scale operations with enhanced automation and advanced analytics<\/li>\n\n\n\n<li><strong>Flexibility:<\/strong> Modular design allows rapid scaling to meet emerging market needs<\/li>\n\n\n\n<li><strong>Workforce Development:<\/strong> Local hiring and training programs to build specialized technical expertise<\/li>\n<\/ul>\n\n\n\n<h2 id=\"h-economic-impact-amp-innovation-ecosystem\" class=\"wp-block-heading\">Economic Impact &amp; Innovation Ecosystem<\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Job Creation:<\/strong> Expected to generate 150-200 high-skilled positions in the Chicago metropolitan area<\/li>\n\n\n\n<li><strong>Academic Partnerships:<\/strong> Potential collaborations with University of Chicago, Northwestern University, and other regional institutions<\/li>\n\n\n\n<li><strong>Supply Chain Development:<\/strong> Stimulates local biomanufacturing supply chain and service provider ecosystem<\/li>\n\n\n\n<li><strong>Technology Transfer:<\/strong> Facilitates knowledge exchange between Chinese and U.S. biotechnology sectors<\/li>\n\n\n\n<li><strong>Innovation Catalyst:<\/strong> Supports acceleration of gene therapy and cell therapy development timelines<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Forward-Looking Statements<\/strong><br>This brief contains forward-looking statements regarding VectorBuilder&#8217;s Chicago facility investment, including implementation timelines, capacity expansion plans, and market impact. Actual results may differ due to risks including regulatory approvals, construction delays, workforce recruitment challenges, and evolving market demand for gene delivery technologies.<a href=\"https:\/\/flcube.com\/\">-Fineline Info &amp; Tech<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>VectorBuilder, a China-based gene delivery technology developer, announced plans to invest USD 50 million to&#8230;<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"googlesitekit_rrm_CAownpewDA:productID":"","_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[7],"tags":[19,1405],"class_list":["post-66611","post","type-post","status-publish","format-standard","hentry","category-company","tag-cro-cmo-cdmo","tag-vectorbuilder"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v27.5 (Yoast SEO v27.7) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>VectorBuilder Commits $50 Million to Chicago Biomanufacturing Hub \u2013 Integrated R&amp;D and GMP Facility to Streamline Gene Delivery Product Development - Insight, China&#039;s Pharmaceutical Industry<\/title>\n<meta name=\"description\" content=\"VectorBuilder, a China-based gene delivery technology developer, announced plans to invest USD 50 million to establish an advanced biomanufacturing and research &amp; development center in Chicago, USA. The integrated facility will unify the company&#039;s complete gene delivery product portfolio under a single operational framework, addressing critical industry challenges in translational efficiency and manufacturing continuity.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/flcube.com\/?p=66611\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"VectorBuilder Commits $50 Million to Chicago Biomanufacturing Hub \u2013 Integrated R&amp;D and GMP Facility to Streamline Gene Delivery Product Development\" \/>\n<meta property=\"og:description\" content=\"VectorBuilder, a China-based gene delivery technology developer, announced plans to invest USD 50 million to establish an advanced biomanufacturing and research &amp; development center in Chicago, USA. The integrated facility will unify the company&#039;s complete gene delivery product portfolio under a single operational framework, addressing critical industry challenges in translational efficiency and manufacturing continuity.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/flcube.com\/?p=66611\" \/>\n<meta property=\"og:site_name\" content=\"Insight, China&#039;s Pharmaceutical Industry\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/profile.php?id=61566606313834\" \/>\n<meta property=\"article:published_time\" content=\"2026-05-28T13:54:38+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-05-28T13:54:40+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"2560\" \/>\n\t<meta property=\"og:image:height\" content=\"1894\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Fineline Cube\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:description\" content=\"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Fineline Cube\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=66611#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=66611\"},\"author\":{\"name\":\"Fineline Cube\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\"},\"headline\":\"VectorBuilder Commits $50 Million to Chicago Biomanufacturing Hub \u2013 Integrated R&amp;D and GMP Facility to Streamline Gene Delivery Product Development\",\"datePublished\":\"2026-05-28T13:54:38+00:00\",\"dateModified\":\"2026-05-28T13:54:40+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=66611\"},\"wordCount\":530,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"keywords\":[\"CRO \\\/ CMO \\\/ CDMO\",\"VectorBuilder\"],\"articleSection\":[\"Company\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=66611#respond\"]}],\"copyrightYear\":\"2026\",\"copyrightHolder\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=66611\",\"url\":\"https:\\\/\\\/flcube.com\\\/?p=66611\",\"name\":\"VectorBuilder Commits $50 Million to Chicago Biomanufacturing Hub \u2013 Integrated R&amp;D and GMP Facility to Streamline Gene Delivery Product Development - Insight, China&#039;s Pharmaceutical Industry\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\"},\"datePublished\":\"2026-05-28T13:54:38+00:00\",\"dateModified\":\"2026-05-28T13:54:40+00:00\",\"description\":\"VectorBuilder, a China-based gene delivery technology developer, announced plans to invest USD 50 million to establish an advanced biomanufacturing and research & development center in Chicago, USA. The integrated facility will unify the company's complete gene delivery product portfolio under a single operational framework, addressing critical industry challenges in translational efficiency and manufacturing continuity.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=66611#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=66611\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=66611#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/flcube.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"VectorBuilder Commits $50 Million to Chicago Biomanufacturing Hub \u2013 Integrated R&amp;D and GMP Facility to Streamline Gene Delivery Product Development\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"name\":\"Insight, China's Pharmaceutical Industry\",\"description\":\"Fineline Insights, Pharma Clarity\",\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/flcube.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\",\"name\":\"Fineline Infomation and Technology\",\"alternateName\":\"Fineline Info & Tech\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"width\":2560,\"height\":1894,\"caption\":\"Fineline Infomation and Technology\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/profile.php?id=61566606313834\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\",\"name\":\"Fineline Cube\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"caption\":\"Fineline Cube\"},\"sameAs\":[\"https:\\\/\\\/flcube.com\"],\"url\":\"https:\\\/\\\/flcube.com\\\/?author=1\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"VectorBuilder Commits $50 Million to Chicago Biomanufacturing Hub \u2013 Integrated R&amp;D and GMP Facility to Streamline Gene Delivery Product Development - Insight, China&#039;s Pharmaceutical Industry","description":"VectorBuilder, a China-based gene delivery technology developer, announced plans to invest USD 50 million to establish an advanced biomanufacturing and research & development center in Chicago, USA. The integrated facility will unify the company's complete gene delivery product portfolio under a single operational framework, addressing critical industry challenges in translational efficiency and manufacturing continuity.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/flcube.com\/?p=66611","og_locale":"en_US","og_type":"article","og_title":"VectorBuilder Commits $50 Million to Chicago Biomanufacturing Hub \u2013 Integrated R&amp;D and GMP Facility to Streamline Gene Delivery Product Development","og_description":"VectorBuilder, a China-based gene delivery technology developer, announced plans to invest USD 50 million to establish an advanced biomanufacturing and research & development center in Chicago, USA. The integrated facility will unify the company's complete gene delivery product portfolio under a single operational framework, addressing critical industry challenges in translational efficiency and manufacturing continuity.","og_url":"https:\/\/flcube.com\/?p=66611","og_site_name":"Insight, China&#039;s Pharmaceutical Industry","article_publisher":"https:\/\/www.facebook.com\/profile.php?id=61566606313834","article_published_time":"2026-05-28T13:54:38+00:00","article_modified_time":"2026-05-28T13:54:40+00:00","og_image":[{"width":2560,"height":1894,"url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","type":"image\/jpeg"}],"author":"Fineline Cube","twitter_card":"summary_large_image","twitter_description":"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM","twitter_misc":{"Written by":"Fineline Cube","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/flcube.com\/?p=66611#article","isPartOf":{"@id":"https:\/\/flcube.com\/?p=66611"},"author":{"name":"Fineline Cube","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a"},"headline":"VectorBuilder Commits $50 Million to Chicago Biomanufacturing Hub \u2013 Integrated R&amp;D and GMP Facility to Streamline Gene Delivery Product Development","datePublished":"2026-05-28T13:54:38+00:00","dateModified":"2026-05-28T13:54:40+00:00","mainEntityOfPage":{"@id":"https:\/\/flcube.com\/?p=66611"},"wordCount":530,"commentCount":0,"publisher":{"@id":"https:\/\/flcube.com\/#organization"},"keywords":["CRO \/ CMO \/ CDMO","VectorBuilder"],"articleSection":["Company"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/flcube.com\/?p=66611#respond"]}],"copyrightYear":"2026","copyrightHolder":{"@id":"https:\/\/flcube.com\/#organization"}},{"@type":"WebPage","@id":"https:\/\/flcube.com\/?p=66611","url":"https:\/\/flcube.com\/?p=66611","name":"VectorBuilder Commits $50 Million to Chicago Biomanufacturing Hub \u2013 Integrated R&amp;D and GMP Facility to Streamline Gene Delivery Product Development - Insight, China&#039;s Pharmaceutical Industry","isPartOf":{"@id":"https:\/\/flcube.com\/#website"},"datePublished":"2026-05-28T13:54:38+00:00","dateModified":"2026-05-28T13:54:40+00:00","description":"VectorBuilder, a China-based gene delivery technology developer, announced plans to invest USD 50 million to establish an advanced biomanufacturing and research & development center in Chicago, USA. The integrated facility will unify the company's complete gene delivery product portfolio under a single operational framework, addressing critical industry challenges in translational efficiency and manufacturing continuity.","breadcrumb":{"@id":"https:\/\/flcube.com\/?p=66611#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/flcube.com\/?p=66611"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/flcube.com\/?p=66611#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/flcube.com\/"},{"@type":"ListItem","position":2,"name":"VectorBuilder Commits $50 Million to Chicago Biomanufacturing Hub \u2013 Integrated R&amp;D and GMP Facility to Streamline Gene Delivery Product Development"}]},{"@type":"WebSite","@id":"https:\/\/flcube.com\/#website","url":"https:\/\/flcube.com\/","name":"Insight, China's Pharmaceutical Industry","description":"Fineline Insights, Pharma Clarity","publisher":{"@id":"https:\/\/flcube.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/flcube.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/flcube.com\/#organization","name":"Fineline Infomation and Technology","alternateName":"Fineline Info & Tech","url":"https:\/\/flcube.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/","url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","width":2560,"height":1894,"caption":"Fineline Infomation and Technology"},"image":{"@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/profile.php?id=61566606313834"]},{"@type":"Person","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a","name":"Fineline Cube","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","caption":"Fineline Cube"},"sameAs":["https:\/\/flcube.com"],"url":"https:\/\/flcube.com\/?author=1"}]}},"jetpack_publicize_connections":[],"jetpack_featured_media_url":"","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/66611","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=66611"}],"version-history":[{"count":1,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/66611\/revisions"}],"predecessor-version":[{"id":66612,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/66611\/revisions\/66612"}],"wp:attachment":[{"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=66611"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=66611"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=66611"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}